Review
Open access
Sep 2026
Engineering mRNA‐LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases
This review surveys recent advances in engineering LNPs that traverse the blood–brain barrier (BBB), evade innate immune surveillance, and achieve cell‐selective expression in the ageing brain and outlines a translational roadmap for brain applications.
A. Belaidi, Denzil Furtado, Francesca M. Alves et al.
· Exploration · 1 citation